Exemplify BioPharma provides integrated end-to-end program and/or portfolio based CMC drug development deliverables to pharmaceutical and biotech partners. Through a combination of program management and coordination, process development laboratories and the provision of CMC regulatory documentation for filing with worldwide regulatory agencies. Exemplify BioPharma is uniquely positioned to deliver CMC success to partner organizations. In addition, Exemplify BioPharma provides consultation and innovative approaches to the challenges of drug development. Using a “PRO” or Partnership Research Organization model, Exemplify BioPharma will target business partners who want to manage their expanding pipelines and financial exposure through partnership with a team of experienced pharmaceutical and biotech experts. These partnerships are available to mid-sized US based pharmaceutical and biotech companies growing through licensing and acquisition; biopharma companies with expanding pipelines who do not want to grow through internal staffing; virtual companies who need compound development support from discovery through clinical phases and international pharmaceutical ventures planning to establish capabilities in the US.